Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.

R Golański, J Golański, K Chizyński, A Iwaszkiewicz, J Zasłonka, T Pietrucha, S Chrul, C Watała

Med Sci Monit 2000; 6(4): CR722-728 :: ID: 432537

Abstract

INTRODUCTION: Excessive blood loss, as a result of augmented postoperativedrainage, is considered one of the most serious cardiosurgical complications. The compounding constitutiveanemia seems particularly harmful for patients with coronary artery disease. Aprotinin (Trasylol), anon-specific serine protease inhibitor, is successfully used to reduce excessive postoperative bleedingin such patients. The aim of our study was to verify the hypothesis whether aprotinin used during cardiopulmonarybypass procedure affects hemostatic parameters, which might be crucial for the elevated risk of thromboemboliccomplications. MATERIAL AND METHODS: The group of 54 patients subjected to coronary artery surgical treatmentincluded 30 patients, who were given intraoperatively 3 million KIU aprotinin each, and 24 subjects non-treatedwith aprotinin. Aliquots of blood were withdrawn at several time intervals, until the 5th day after theoperation. Whole blood platelet activation and reactivity (the expressions of P-selectin and glycoproteinIb) were monitored by means of flow cytometry. In addition, several plasma parameters, like PAI-1, t-PA,D-dimers, prothrombin fragment F1 + 2, fibrinogen, ATIII activity, troponin I and CK-MB, as well as plateletcount were determined at each time point. RESULTS: In this study we confirmed the essential advantageof the use of aprotinin: both the postoperative blood drainage and the blood units to be transfused postoperativelyto cardiosurgical patients were vastly reduced in the aprotinin-treated subjects. The enhanced overallfrequency of perioperative myocardial infarction events was not attributed to this group of patients,nor the non Q-wave infarctions were observed more often in patients treated with aprotinin. In thesepatients, fibrinolysis parameters tended to be depressed (with increased PAI-1 dominating over elevatedt-PA) on the first day after the operation, and no significant differences with regard to fibrinogen,prothrombin fragment F1 + 2, troponin I and platelet count. There was a continuous rise in D-dimers inall the postoperative patients, which lasted until the third day and tended to reach plateau at the 5thday after the operation. We failed to reveal the preventive effects of aprotinin on platelet function:both platelet activation and reactivity remained apparently unchanged. Overall, our results rather supportthe reasoning on the advantageous effects of low doses of aprotinin. The use of this inhibitor reducesthe risk of postoperative undesirable bleeding and results in a decreased postoperative drainage andreduced transfused blood units. On the other hand, however, a higher incidence of perioperative Q-waveinfarction in the aprotinin-treated patients, although purely apparent and not statistically significant,might question the unlimited safety of the use of aprotinin in cardiovascular operations.

Keywords: thromboembolism

0 Comments

Editorial

01 January 2023 : Editorial  

Editorial: Current Status of Two Adjuvanted Malaria Vaccines and the World Health Organization (WHO) Strategy to Eradicate Malaria by 2030

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.939357

Med Sci Monit 2023; 29:e939357

SARS-CoV-2/COVID-19

26 January 2023 : Editorial  

Editorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread

Med Sci Monit In Press; DOI: 10.12659/MSM.939580  

19 January 2023 : Clinical Research  

Evaluation of Health-Related Quality of Life and Mental Health in 729 Medical Students in Indonesia During ...

Med Sci Monit In Press; DOI: 10.12659/MSM.938892  

27 December 2022 : Clinical Research  

Effect of Physiotherapy to Correct Rounded Shoulder Posture in 30 Patients During the COVID-19 Pandemic in ...

Med Sci Monit 2022; 28:e938926

In Press

27 Jan 2023 : Database Analysis  

Association Between Neutrophil-Lymphocyte Ratio and All-Cause Mortality in Critically Ill Patients with Chr...

Med Sci Monit In Press; DOI: 10.12659/MSM.938554  

27 Jan 2023 : Clinical Research  

Proposal for a Simple Equation for Limb Muscle Weight Calculation

Med Sci Monit In Press; DOI: 10.12659/MSM.938606  

26 Jan 2023 : Editorial  

Editorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread

Med Sci Monit In Press; DOI: 10.12659/MSM.939580  

20 Jan 2023 : Clinical Research  

A Study of 42 Partially Edentulous Patients with Single-Crown Restorations and Implants to Compare Bone Los...

Med Sci Monit In Press; DOI: 10.12659/MSM.939225  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750